Home / Stock ratings / Healthcare Stocks / UNH
Stock rating · Hospital & Medical Service Plans
UnitedHealth Group Incorporated (UNH) Stock Rating & Analysis
As of November 20, 2026, MELANY rates UnitedHealth Group Incorporated 64 out of 100 (Hold). Its highest factor score is earnings track record at 88, and its lowest is price momentum at 44.
UNH · composite score
About UnitedHealth Group Incorporated
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. A leader in employer-sponsored, self-directed, and government-backed plans, it has large scale in medical insurance, and its Optum franchises extend the company across pharmaceutical benefits, outpatient care, and analytics for affiliates and third parties.
Rating as of 2026-11-20 · this is a dated snapshot; the live rating and the live price are in the app (the rating is part of Pro, free for 30 days).
How UNH's rating has moved
- 0Past two weeks, since Nov 6: score held at 64.
Weekly points: Nov 6: 64 · Nov 20: 64 (this page).
From MELANY's own dated rating record. A tier change is reported as a move between named tiers; the score carries the direction.
Why UNH scores 64/100
UNH's 8 factor scores run from 44 to 88, and 4 of them sit above its composite of 64. Here is how UNH breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- P/E 19.4x vs sector 22.0x median
- PEG ratio 0.89 (< 1 = undervalued)
- FCF yield 7.5%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 3 of last 4 quarters
- Avg EPS beat +12%
What Wall Street price targets and revisions are signalling.
- Analyst targets 40% upside
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How UNH compares
As of November 20, 2026, UnitedHealth Group Incorporated ranks 7th of 20 in Healthcare Stocks, where the average score is 62.
Key risks for UNH
- Performance partly driven by Healthcare sector, rotation away from this theme would hurt
Sector and theme context
UnitedHealth Group Incorporated sits in the Healthcare sector theme, which MELANY currently rates 99/100 for strength. Theme strength feeds UNH's momentum and catalyst factors above.
Tracking UNH
UnitedHealth Group Incorporated rates Hold right now, so MELANY is not flagging a fresh entry. Add UNH to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates UNH
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. UnitedHealth Group Incorporated's 64/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about UNH
Is UnitedHealth Group Incorporated (UNH) a buy?
As of 2026-11-20, MELANY rated UnitedHealth Group Incorporated Hold with a composite score of 64/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
How has UNH's rating changed recently?
As of 2026-11-20, MELANY scores UNH 64/100 (Hold); 2 weeks earlier (Nov 6) it was 64. These points come from MELANY's own dated rating record.
How does UNH rank against similar companies?
As of November 20, 2026, UnitedHealth Group Incorporated ranks 7th of 20 in MELANY's Healthcare Stocks list, where the average score is 62. Among the other names in the list, the highest scores belong to REGN (74) and MDT (71).
Should I buy UnitedHealth Group Incorporated stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates UnitedHealth Group Incorporated (UNH) Hold with a composite of 64/100 as of 2026-11-20. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the UNH stock price forecast?
MELANY does not publish price targets or forecasts for UNH. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 64/100 across eight factors for UnitedHealth Group Incorporated, and re-scores automatically as new price, earnings, and fundamental data arrive. What it does read for UNH as of 2026-11-20: its analyst sentiment factor is 83/100 (Analyst targets 40% upside), and its price momentum factor is 44/100.
Is UNH stock overvalued or undervalued?
MELANY's valuation factor currently reads 70/100 for UnitedHealth Group Incorporated, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives UNH's read.
What price should I buy UNH at?
MELANY is not flagging a fresh entry for UNH at its current Hold rating, so there is no entry zone to publish right now. Add UNH to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying UNH stock?
The top risks MELANY currently flags for UnitedHealth Group Incorporated: Performance partly driven by Healthcare sector, rotation away from this theme would hurt. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is UnitedHealth Group Incorporated a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 47/100 for UnitedHealth Group Incorporated, and earnings track record, at 88/100. The 64/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will UNH stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 44/100 for UNH right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this UNH rating?
The rating on this page is a snapshot of MELANY's read as of 2026-11-20, and the score is not recomputed on this page. MELANY re-scores UNH as new price, earnings, and fundamental data arrive; the current rating and the live price are in the app (the rating is part of Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, UNH included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.